# FDA Inspection 1216119 - Alcresta Therapeutics, Inc. - August 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/alcresta-therapeutics-inc/7f7aec32-4e00-4453-adf7-62ae00a14f53
Source feed: FDA_Inspections

> FDA Inspection 1216119 for Alcresta Therapeutics, Inc. on August 16, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216119
- Company Name: Alcresta Therapeutics, Inc.
- Inspection Date: 2023-08-16
- Classification: No Action Indicated (NAI)
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [FDA Inspection 1216119 - 2023-08-16](https://www.keypedia.com/records/fda_inspections/alcresta-therapeutics-inc/50aaf076-0a35-4db0-ba5e-0ad97fcd0a24)
- [FDA Inspection 1153712 - 2021-09-13](https://www.keypedia.com/records/fda_inspections/alcresta-therapeutics-inc/4c6896bc-267d-4289-9561-a0c838c7b461)
- [FDA Inspection 1037963 - 2018-01-08](https://www.keypedia.com/records/fda_inspections/alcresta-therapeutics-inc/02f52645-ad29-47b8-ab9a-5051797d0f4a)
- [FDA Inspection 1037963 - 2018-01-08](https://www.keypedia.com/records/fda_inspections/alcresta-therapeutics-inc/c86d1c58-f11c-4437-a0a6-6f9c43d6a22b)

Company: https://www.keypedia.com/companies/alcresta-therapeutics-inc/73eb0dc9-c837-4560-a6c2-d9fd5b25d954

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7